久久午夜影院,国产大鸡巴九色,丰满人妻一区=区三区在线视频53,五月天婷婷激情四射在线观看

    <source id="7npa8"><tr id="7npa8"><dfn id="7npa8"></dfn></tr></source>
    1. 產(chǎn)品中心您現(xiàn)在的位置:首頁 > 產(chǎn)品展示 > > 天然免疫研究產(chǎn)品 > LPS-EB

      LPS-EB

      更新時(shí)間:2022-01-29

      簡(jiǎn)要描述:

      LPS is the principal component of Gram-negative bacteria that activates the innate immune system through its recognition by Toll-like receptor 4 (TLR4). This leads to a signaling cascade that ultimat…

      型號(hào):廠商性質(zhì):代理商瀏覽量:920

      Lipopolysaccharide from Escherichia coli 0111:B4

      LPS is the principal component of Gram-negative bacteria that activates the innate immune system through its recognition by Toll-like receptor 4 (TLR4). This leads to a signaling cascade that ultimately results in the activation of NF-κB and the production of proinflammatory cytokines [1]. LPS-EB is a preparation of smooth (S)-form LPS purified from the Gram-negative E. coli 0111:B4, a pathogenic serotype of E. coli known to cause significant gastric disease [2,3].

       

      InvivoGen provides LPS-EB with two grades of purity:

      • LPS-EB is a standard lipopolysaccharide (LPS) preparation extracted by a phenol-water mixture. LPS-EB contains other bacterial components, such as lipoproteins, and therefore stimulates both TLR4 and TLR2.

      • LPS-EB Ultrapure is extracted by successive enzymatic hydrolysis steps and purified by the previously described phenol-TEA-DOC extraction protocol [4]. This process removes contaminating lipoproteins, and therefore LPS-EB Ultrapure only activates TLR4. 

       

      References:

      1. Kuzmich, N.N. et al., 2017. TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis. Vaccines (Basel) 5unol. 165(2):618-22.
      2. Coleman, W.G., Jr. et al., 1977. Genetic analysis of Escherichia coli O111:B4, a strain of medical and biochemical interest. J Bacteriol 130, 656-660.
      3. Viljanen, M.K. et al., 1990. Outbreak of diarrhea due to Escherichia coli O111:B4 in schoolchildren and adults: association of Vi antigen-like reactivity. Lancet 336, 831-834.
      4. Hirschfeld M. et al., 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol. 165(2):618-22.

       

      Specifications

      LPS-EB

      Specificity: TLR4 and TLR2 agonist.

      Solubility: 5 mg/ml in water.

      Working concentration: 10 ng - 10 µg/ml.

      LPS-EB Ultrapure

      Specificity: TLR4 agonist.

      Solubility: 5  x 10e6 EU/ml in water.

      Working concentration: 10e1 - 10e4 EU/ml.


      Contents

      LPS-EB

      • 5 mg lipopolysaccharide from E. coli 0111:B4 (LPS-EB ).

      • 1.5 ml endotoxin-free water.

      LPS-EB Ultrapure

      • 5 x 106 EU  ultrapure lipopolysaccharide from E. coli 0111:B4 (LPS-EB Ultrapure).

      • 1.5 ml endotoxin-free water.

       

       Products are shipped at room temperature.

       Upon receipt product should be stored at -20°C.

       Lyophilized product is stable 1 year at -20°C.

      Resuspended product is stable 1 month at 4°C and 6 months at -20°C.


      如需購(gòu)買或咨詢?cè)摦a(chǎn)品技術(shù)問題,請(qǐng)聯(lián)系Invivogen一級(jí)代理商--欣博盛生物

      留言框

      • 產(chǎn)品:

      • 您的單位:

      • 您的姓名:

      • 聯(lián)系電話:

      • 常用郵箱:

      • 省份:

      • 詳細(xì)地址:

      • 補(bǔ)充說明:

      • 驗(yàn)證碼:

        請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7